After a miR-20b mimic is injected into TB mice, macrophages polarize into the M2 type, alleviating inflammation via the suppression of the NLRP3/caspase 1/IL-1β pathway, which may reflect a novel molecule-based therapeutic strategy (142). The gene discussed is NLRP3; the disease is tuberculosis.